Pure Biologics Current Liabilities

Current Liabilities of Pure Biologics is 15.40 M PLN in 2026.

Current Liabilities of Pure Biologics changed from 7.21 M PLN to 15.40 M PLN, representing a 113.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Pure Biologics historically and in real time.